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Synaptopodin expression in idiopathic nephrotic syndrome of The visceral glomerular epithelial cell or podocyte is
childhood. a terminally differentiated cell in the glomerulus that
Background. Synaptopodin is a proline-rich protein inti- plays an important role in glomerular ultrafiltration. Podo-
mately associated with actin microfilaments present in the po-
cytes stabilize the glomerular capillaries, participate indocytes’ foot processes. We investigated for synaptopodin ex-
the barrier function, modulate the ultrafiltration coeffi-pression in children with idiopathic nephrotic syndrome (INS),
cient Kf, and model the glomerular basement membraneincluding minimal change disease (MCD), diffuse mesangial
hypercellularity (DMH), and focal segmental glomerulosclero- [1]. Podocytes have three structurally and functionally
sis (FSGS); in children with congenital nephrotic syndrome different segments: the cell body, major processes, and
of the Finnish type (CNF); and in normal kidney tissue. In foot processes [1]. Microtubules in the major processesparticular, we examined whether an association exists between
are connected to an actin-based contractile microfila-synaptopodin expression in podocyte cells and the response
ment apparatus in the foot process that allows the podo-to steroids in INS, and whether synaptopodin expression can
predict FSGS upon the initial kidney biopsy in children who cytes to maintain and alter cell shape and perform slow
progress from MCD or DMH to FSGS. and directed movements of the foot processes [1, 2]. The
Methods. Immunohistochemistry was performed for synap- foot processes and slit diaphragms of the podocyte form
topodin expression on renal tissues from MCD (N 5 18), DMH
a barrier, which allows only certain molecules to filter(N 5 7), FSGS (N 5 13), CNF (N 5 9), and normal children
into the urine, depending on their size, charge, and shape.(N 5 7). Synaptopodin expression in nonsclerosed glomeruli
Synaptopodin is a linear, proline-rich protein, intimatelywas quantitated by computerized image analysis on the Opti-
mase software for both luminance (L) and percentage of glo- associated with the actin microfilament, and it is ex-
merular area (A). pressed exclusively in the foot process of podocytes in
Results. Synaptopodin expression was absent in areas of the kidney and in the dendritic spines of the telencephalic
sclerosis. In nonsclerosed glomeruli, synaptopodin was signifi-
synapses [3]. Synaptopodin is believed to modulate thecantly less expressed in all groups of INS and in CNF compared
actin-based shape and motility of the podocyte foot proc-with normal (P , 0.0001 for both L and A, in each MCD,
esses [3]. It is present in only the completely differenti-DMH, FSGS, and CNF). In INS, synaptopodin expression de-
creased in order from MCD to DMH to FSGS, reaching statisti- ated podocyte, and its expression begins in the capillary
cal significance between MCD and FSGS (P 5 0.001 for L and loop stage of glomerular development, at which time the
P 5 0.05 for A). Greater synaptopodin expression in podocytes formation of foot processes also commences [4, 5]. While
was associated with a significantly better response to steroid
synaptopodin is expressed in the foot processes, Wilm’stherapy (P , 0.05 for both L and A). On the other hand,
tumor-1 (WT-1) protein is exclusively expressed in thethe expression of synaptopodin did not predict progression of
MCD or DMH to FSGS. nucleus of the podocyte [6].
Conclusion. We conclude that measurement of synapto- On biopsy, the common histologies of idiopathic ne-
podin has the potential to be used as a marker to study the phrotic syndrome of childhood (INS) include minimal
alteration in podocyte cell and response to therapy in INS. change disease (MCD), diffuse mesangial hypercellular-
ity (DMH), and focal segmental glomerulosclerosis (FSGS)
[7]. Idiopathic nephrotic syndrome of childhood is char-
Key words: idiopathic nephrotic syndrome, podocyte foot processes,
acterized by effacement of foot processes, apical dis-steroids, sclerosed glomeruli, minimal change disease, renal disease in
children. placement of slit diaphragms, and detachment of podo-
cytes from the glomerular basement membrane that areReceived for publication April 10, 2000
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uria [11, 12]. MCD is characterized by minimal changes CNF 9, and normal 7. The age at the time of biopsy was
noted. Children with INS were divided into two groupsin the glomerulus. It responds well to steroid treatment
and rarely progresses to renal failure. On other hand, based on clinical response to steroid therapy. The stan-
dard definition for response to steroid in INS was usedFSGS is characterized by segmental glomerular hyalino-
sis and sclerosis; it responds poorly to steroid treatment [14]. Children in group A (N 5 19) went into remission
with steroid therapy with/without an eight-week courseand frequently progresses to renal failure [13]. The clini-
cal course of DMH lies between MCD and FSGS. MCD of cyclophosphamide. Eleven children had received ste-
roids only, while eight had received in addition an eight-and DMH have been observed to progress to FSGS on
subsequent kidney biopsies, suggesting that these lesions week course of cyclophosphamide. Children in group B
(N 5 19) were either steroid resistant (N 5 12) or steroidlie on a continuum [14–17]. The initial therapy to all
forms of INS is by steroids, to which the response can dependent (N 5 7) needing additional immunosuppres-
sive therapy in different combinations, such as cyclophos-be diverse, and certain children may need additional im-
munosuppressive therapy to which they may or may not phamide (N 5 5), chlorambucil (N 5 5), cyclosporine
(N 5 12), azathioprine (N 5 1), or FK 506 (N 5 1). Norespond.
Congenital nephrotic syndrome of the Finnish type further subgrouping was done, as the lack of adequate
numbers in various subgroups made statistical analysis(CNF) occurs from a genetic mutation in the nephrin
protein, normally present in the slit diaphragm of the superfluous. An additional four children who had pro-
gressed from MCD or DMH to FSGS were analyzedfoot processes [18, 19]. The disease is characterized by
massive proteinuria starting very early in life, at times separately.
Serial 3 mm sections were obtained from the casesin utero [19, 20]. It does not respond to steroids and needs
aggressive treatment, including continuous albumin infu- listed previously in this article and were air dried and
heat fixed on slides. The sections were deparaffinized withsions, bilateral nephrectomy, and renal replacement ther-
apy in infancy [20]. xylene and iodine and were rehydrated in graded series
of alcohol. The sections were treated with Target Re-A decrease or loss of synaptopodin expression was
trieval Solution (Dako #S1700; Dako Corp., Carpinteria,previously observed in idiopathic FSGS, collapsing FSGS,
CA, USA) in a steamer at 90 to 958C for 20 minutes andand HIV-associated nephropathy [21–23]. On the other
then cooled for 15 minutes. The endogenous avidin andhand, the expression was normal in MCD, mesangioprol-
biotin activity was blocked by egg white and skimmediferative glomerulonephritis, membranous nephropathy,
milk as described by Miller et al [25]. The sections wereand IgA nephropathy [21–23]. Barisoni et al concluded
stained by immunohistochemistry on the automatedthat in collapsing FSGS, there is a dysregulation of the
Dako Autostainer 3400 using Dako’s LSAB 1 immuno-podocyte phenotype, which is characterized by lack of
peroxidase kit with streptavidin conjugated to horserad-synaptopodin expression [21]. Based on these findings,
ish peroxidase. Anti-synaptopodin, a mouse monoclonalwe investigated for synaptopodin expression in INS,
antibody (ARP Inc., Belmont, MA, USA) was used in 1:1CNF, and normal children to examine whether it could
dilution for synaptopodin staining. Anti-human WT-1, abe a key for differentiating among the various entities of
mouse monoclonal antibody (Dako Corp.), was used inINS. We also looked for a possible association between
1:100 dilution for WT-1 staining. The staining for WT-1synaptopodin expression in INS and response to steroids
was performed for tissue quality control for fixation andand whether synaptopodin expression could predict
processing of the archived tissue. Both positive and nega-FSGS on the initial biopsy in children who progress from
tive controls for synaptopodin and WT-1 were run withMCD or DMH to FSGS.
each run on the Dako Autostainer 3400. Diaminobenzi-
dine was used as the chromogen.
METHODS Kidney biopsies stained by immunohistochemistry for
Kidney biopsies from children with INS were included WT-1 and synaptopodin were first examined by light
in the study only if (1) the histology was consistent with microscopy. On light microscopy, WT-1 expression was
MCD, DMH, or FSGS as described by the International scored from 0 to 21. The characteristics of synaptopodin
Study of Kidney Disease in Children [24]; (2) patients expression in each group were initially evaluated under
had a minimum of two years of follow-up from the pri- light microscopy and were then further analyzed by com-
mary diagnosis of INS to ascertain the response to steroid puterized image analysis using Optimase software. Opti-
therapy; and (3) the tissue in the paraffin block had at mase is a standard image analysis program used for
least five nonsclerosed glomeruli. Control tissue (nor- quantitative immunohistochemistry [26–28]. Synapto-
mal) from nephrectomy specimens from children with podin stands out as a distinct brown stain against the
Wilm’s tumor and kidney tissue from children with CNF light background of the remaining glomerulus. In each
were included in the study as well. In all, 54 kidney biopsy, the five maximally stained nonsclerosed glome-
ruli were analyzed for both luminance and percentagebiopsies were investigated: MCD 18, DMH 7, FSGS 13,
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Fig. 1. Synaptopodin expression in nonscle-
rosed glomerulus in (A) normal kidney [area
of staining, 44.6%; luminance gray value (GV),
86.5], (B) minimal change disease (area of stain-
ing, 27.6%; luminance GV, 117.5), (C) focal
segmental glomerulosclerosis (area of staining,
1.9%; luminance GV, 160.5), and (D) congeni-
tal nephrotic syndrome of the Finnish type
(area of staining, 1.5%; luminance GV, 158.7).
Immunohistochemistry staining using diami-
nobenzidine as chromogen is shown (3400).
glomerular area of synaptopodin staining. Five glomeruli was similar to normals but was weaker in intensity, and
are considered an adequate sample for diagnosis [29, 30]. like in normals, it was linear along the glomerular base-
In each glomerulus, for luminance, an average gray value ment membrane; however, at times attenuated in thick-
(GV) from 0 to 255 was obtained from 320 data points, ness with minimal segmental interruption and minimal
with 0 being equivalent to black and 255 equivalent to granulation (Fig. 1B). In FSGS, in nonsclerosed glomer-
white. The lower the luminance GV, the higher is the uli, synaptopodin expression was very weak with occa-
intensity of staining. The percentage glomerular area of sional glomeruli showing no expression, and the linear
staining was calculated by drawing a region of interest expression changed to more segmental pattern with
around the glomerulus and calculating the percentage marked interruption (“patchy”) and coarse granulations
of area stained with synaptopodin within the glomerulus (Fig. 1C). In segmentally sclerosed glomerulus, the sy-
at a fixed color threshold. For each biopsy, the average naptopodin expression was absent in areas of sclerosis
for luminance GV and percentage glomerular area from and was patchy in the rest of the glomerulus. The pattern
the five glomeruli was used. To compare luminance GV for DMH was in between MCD and FSGS. In CNF, the
and percentage glomerular area among the five groups synaptopodin expression was extremely weak (Fig. 1D).
of MCD, DMH, FSGS, CNF, and normal children, uni- The results of synaptopodin expression by quantitative
variate analysis of variance (ANOVA) was used. Box computerized image analysis, for both luminance gray
plots show the distribution of data in each group: the value and percentage glomerular area of staining in non-
minimum, 25th percentile, 50th percentile, 75th percen- sclerosed glomeruli in the five groups, and the mean 6
tile, and maximum value. Two-tailed unpaired Student’s SD for age are shown in Table 1. Children with FSGS
t test was used to compare groups A and B and mean were significantly older, and those with CNF were sig-
age among the study groups, and paired t test for analysis nificantly younger than controls. The distribution of data
of the group, which progressed to FSGS.
of synaptopodin expression in normal, MCD, DMH,
FSGS, and CNF children is shown as box plots for lumi-
RESULTS nance GV in Figure 2A and percentage glomerular area
in Figure 2B. The results of univariate ANOVA of theOn light microscopy, WT-1 and synaptopodin expres-
data presented in Figure 2 are shown in Tables 2 and 3,sion were absent in areas of sclerosis. In nonsclerosed
respectively. Synaptopodin was significantly less expressedglomeruli, WT-1 expression was 21 in all normal, MCD,
in MCD, DMH, FSGS, and CNF children comparedDMH, FSGS, and CNF tissue specimen. In normal chil-
with normal (P , 0.0001 for both luminance and area).dren, the morphology of synaptopodin expression was
Among the INS entities, synaptopodin expression de-intense, linear along the glomerular basement membrane,
creased in order for both luminance and percentage glo-thick with very minimal segmental interruption and mini-
merular area from MCD to DMH to FSGS, reachingmal granulation (that is, granular pattern in staining; Fig.
1A). In MCD, the qualitative expression of synaptopodin statistical significance between MCD and FSGS (P 5
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Table 1. Age of patients and synaptopodin expression on computerized image analysis using Optimase software for luminance on a gray
scale (GV) and percentage glomerular area stained for synaptopodin
Normal MCD DMH FSGS CNF
(N 5 7) (N 5 18) (N 5 7) (N 5 13) (N 5 9)
Age years 3.561.9 5.263.5 5.363.6 9.263.8 0.860.2
Normal vs. (P value) — 0.22 0.26 0.001 0.0008
Luminance GV 78.8612.2 129.9616.8 143.6623.9 155.8613.4 148.564.6
Area percentage 45.766.6 15.869.6 11.4612.0 6.466.5 5.663.5
The lower the luminance GV, the higher is the intensity of staining. The results are expressed as mean 6 SD. Abbreviations are: MCD, minimal change disease;
DMH, diffuse mesangial hypercellularity; FSGS, focal segmental glomerulosclerosis; and CNF, congenital nephrotic syndrome of the Finnish type.
Table 2. Univariate analysis of variance (ANOVA) for normal,
MCD, DMH, FSGS and CNF for luminance GV
based on data presented in Figure 2A
95% Cl of mean difference
Mean Lower Upper
Group difference P boundary boundary
Normal
MCD 250.63 ,0.0001 270.26 230.99
DMH 266.91 ,0.0001 290.47 243.34
FSGS 274.74 ,0.0001 295.42 254.08
CNF 269.75 ,0.0001 291.97 247.54
MCD
DMH 216.27 0.14 235.91 103.36
FSGS 224.12 0.001 240.16 208.07
DMH
FSGS 207.84 0.81 228.51 112.82
Abbreviations are in Table 1.
Table 3. Univariate analysis of variance (ANOVA) for normal,
MCD, DMH, FSGS and CNF for percent glomerular area based
on data presented in Figure 2B
95% Cl of mean difference
Mean Lower Upper
Group difference P boundary boundary
Normal
MCD 29.53 ,0.0001 18.78 40.28
DMH 34.99 ,0.0001 22.09 47.89
FSGS 38.27 ,0.0001 26.96 49.58
CNF 40.09 ,0.0001 27.93 52.26
MCD
DMH 05.46 0.61 25.29 16.21
FSGS 08.74 0.05 0.04 17.52
DMH
FSGS 03.28 0.92 28.03 14.59
Abbreviations are in Table 1.
Fig. 2. Box plot distribution of data for synaptopodin expression by
(A) luminance gray value (GV) and (B) percentage of glomerular area
in nonsclerosed glomeruli in normal, minimal change disease (MCD),
diffuse mesangial hypercellularity (DMH), focal segmental glomerulo- podin expression in group A was 132.3 6 18.8 versus
sclerosis (FSGS), and congenital nephrotic syndrome of the Finnish group B 149.0 6 18.9 (P 5 0.01), and the percentagetype (CNF).
glomerular area for synaptopodin expression in group
A was 15.5% 6 9.0% versus group B, 8.8% 6 10.3%
(P 5 0.039). In group A, the predominant diagnosis was
MCD (N 5 14), and in group B, it was FSGS (N 5 12).0.001 for luminance GV and P 5 0.05 for percentage
The sensitivity and specificity for synaptopodin expres-glomerular area).
sion and good steroid response at luminance GV of ,140The distribution of data in group A and B is shown
as box plots in Figure 3. The luminance GV for synapto- and percentage glomerular area of .12% were 68.4 and
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DISCUSSION
Synaptopodin is a linear proline-rich protein that is
intimately associated with actin microfilaments present
in the foot processes of the podocytes. In a puromycin
model of nephrotic syndrome, the actin cytoskeletal
structure is disaggregated with onset of proteinuria and is
completely restored on resolution of proteinuria [11, 12].
One would expect synaptopodin to be altered in INS
because of its association with the actin cytoskeletal ap-
paratus. We did observe a decrease in synaptopodin ex-
pression in INS with a decrease in order from MCD to
DMH to FSGS. Barisoni et al reported loss of synapto-
podin in collapsing FSGS and HIV nephropathy, but
found no difference between normal and MCD [21].
Kemeny et al observed decrease in synaptopodin even
in early stages of idiopathic FSGS but preserved in MCD
[22]. In both studies, synaptopodin was reported as either
absent or present, but no attempt was made to quantitate
the expression [21, 22]. Indeed, in our study on light
microscopy, the qualitative morphological appearance
of synaptopodin in MCD was almost similar to that of
normal (Fig. 1). However, the expression of synapto-
podin was significantly different on quantitative compu-
terized image analysis (Tables 1–3 and Fig. 2). It thus
seems that the loss of synaptopodin expression is not an
“all or none phenomenon,” as suggested in earlier stud-
ies, but may vary quantitatively from one entity to an-
other, as well as among children with the same histology
(Figs. 1 and 2). In support of our observation of the
importance of quantitative analysis was the finding of
intermediate expression of synaptopodin in DMH biop-
sies, which has long been regarded histologically and
Fig. 3. Box plot distribution of data for synaptopodin expression by clinically as intermediate between MCD and FSGS [17].
(A) luminance gray value (GV) and (B) percentage of glomerular area Indeed, the synaptopodin expression was between MCDin nonsclerosed glomeruli in group A (steroid 6 cyclophosphamide
and FSGS (Table 1). Furthermore, our observation ofresponsive) and group B (steroid resistant or dependent requiring
additional immunosuppressive therapy). Outliers are shown as small much attenuation of synaptopodin expression in FSGS
circles. rather than complete disappearance is supported by the
report by Kihara et al [23]. As in other studies, synapto-
podin and WT-1, which are exclusively expressed in po-
docytes, were absent in areas of sclerosis following re-78.9%, respectively, and the positive predictive value
placement of podocytes and other glomerular cells byand negative predictive value were 76.5 and 71.4%, re-
hyaline and fibrous tissue [21, 22].spectively.
Could the observed difference in synaptopodin ex-
In four children with progression from MCD or DMH
pression between INS and normal children be age related
to FSGS on successive biopsies, synaptopodin expression (Table 1)? Although children with FSGS were older,
was lower on final biopsy with FSGS (luminance GV, there was no significant difference between the ages of
163.0 6 17.1; percentage glomerular area, 3.0% 6 4.8%) children with MCD or DMH and normal children. There
compared with initial biopsy (luminance GV, 135.6 6 was no correlation between luminance GV or percentage
14.9; percentage glomerular area, 13.4% 6 8.6%); how- glomerular area and age of the children (data not shown).
ever, because of the small number of subjects, the differ- Furthermore, despite the difference in ages between chil-
ence did not reach statistical significance. The results dren with FSGS and those with CNF, the expression of
from the initial biopsy in the four children resembled synaptopodin in both groups was very similar (Table 1
the findings in other children with MCD and DMH and Fig. 2). There was no difference between Caucasian
and African American children (data not shown). Hence,rather than FSGS.
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it seems unlikely that either age or race played a factor evaluate for any association between steroid response
and synaptopodin expression. Unlike adults with INS,in the expression of synaptopodin.
Was the observed difference in synaptopodin expres- 24-hour proteinuria quantitation is not performed on a
routine basis in children with INS, and thus, we did notsion between INS and normal children the result of loss
of podocytes from the glomerulus or possibly an artifact? have the data on 24-hour proteinuria in all children at
the time of biopsy to estimate a correlation betweenThe loss of podocytes alone cannot explain the loss of
synaptopodin expression in children with INS, as unlike proteinuria and synaptopodin expression. There was no
difference between onset of nephrotic syndrome andchildren with inflammatory glomerulonephritis, loss of
podocytes in the urine is not observed in children with timing of renal biopsy between the different groups (data
not shown). Only four children in the described case seriesMCD [31]. Using double staining technique, Kemeny et
al showed a decrease in synaptopodin expression in FSGS have either elevated creatinine or have progressed to
end-stage renal failure, and therefore, we did not corre-without loss of podocytes [22]. Synaptopodin and WT-1
are exclusively expressed in podocytes, the former in the late synaptopodin expression and renal outcome as the
sample size was too small to make any statistical analysis.foot processes and the latter in the nucleus. In our study,
the WT-1 expression was abundant in all five categories, Children with INS may progress from MCD or DMH
to FSGS. It would be advantageous to have a markersuggesting that the loss of synaptopodin in INS was not
the result of disappearance of podocytes. Therefore, we by which one could predict FSGS as early as the initial
biopsy that still shows findings of MCD or DMH. In fourdo not believe that the observed loss of synaptopodin
expression in INS could have been an artifact. children who upon their renal biopsies progressed from
MCD or DMH to FSGS, synaptopodin expression failedMinimal change disease and DMH have been shown
to progress to FSGS, and the three entities are believed to predict FSGS on their initial biopsy, as its expression
on those biopsies was closer to that observed in MCDto lie along a continuum [14–17]. In most children, MCD
responds well to steroid therapy and has a benign clinical rather than FSGS. The sample size was too small to
reach a definite conclusion, and therefore, the predictivecourse, while FSGS responds poorly to steroid therapy
and carries a guarded prognosis for chronic renal failure, accuracy of this method cannot be ruled out completely
and needs to be investigated further.while DMH has a clinical course in between the two.
Thus, on scale of severity, the severity in INS increases As discussed previously in this article, the severity in
INS increases in order from MCD to DMH to FSGS. Inin order from MCD to DMH to FSGS. The treatment
of all three entities starts with corticosteroids. Some chil- our study, we observed the following: (1) synaptopodin
expression decreased significantly in order from normaldren have a good response to steroids or may need an
additional short course of cyclophosphamide to enter to MCD to DMH to FSGS; (2) synaptopodin expression
decreased significantly in order from normal to group Aremission. They are also regarded to have a better prog-
nosis (group A). In other children who do not respond to to group B; and (3) in children who progressed from
MCD or DMH to FSGS, synaptopodin expression wasthe previously mentioned protocol, aggressive treatment
with additional immunosuppressive drugs is required. lower on final biopsy with FSGS compared with the
initial biopsy. These findings cumulatively suggest thatThe prognosis in that group is more guarded (group B).
We found that children in group A had better expression synaptopodin expression decreases with increasing se-
verity of INS. The disease process in MCD, DMH, andof synaptopodin than those in group B (Fig. 3). Not
surprisingly, group A was comprised mainly of MCD FSGS is believed to have an immunologic basis, which
has still not been well elucidated. The characteristicand group B of FSGS children. However, in spite of the
statistical significance between groups A and B, the data changes of INS are seen in the podocyte cell, and both
albuminuria and FSGS can be produced in vivo by iso-could not well predict the steroid responsiveness for the
individual patient. This could partially be explained by lated podocyte injury in experimental animals [32, 33].
The decrease in synaptopodin expression in podocytesthe fact that biopsies of MCD were biased toward more
severe cases of MCD, as children with MCD with imme- indirectly reflects the magnitude of damage suffered by
the podocyte cell with increasing severity in INS.diate response to steroids do not undergo a biopsy. It is
thus possible that the difference between groups A and To test the hypothesis of whether the alteration in
synaptopodin expression is a generalized podocyte cellB would have been stronger if we had biopsy material
from all children with MCD. The response to immuno- phenomenon and not necessarily related to an immuno-
logic injury in INS or to immunosuppressive treatment,suppression treatment in INS lies along a continuum,
and hence, it is difficult to categorize them clearly. The we evaluated synaptopodin expression in CNF, a nonim-
mune podocyte disease, which is due to mutation in theclinical relevance and statistical strength were lost on
attempts to subgroup the data further, and thus, the nephrin protein and is not treated with immunosuppres-
sive medications [18, 19]. We found synaptopodin ex-biopsies were grouped empirically into two groups, as
discussed previously in this article. The purpose was to pression to be decreased also in CNF. Shih et al have
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Williams & Wilkins, 1994, pp 767–787
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sclerosis. Nephron 35:225–231, 1983sion is not a part of primary pathophysiological mecha-
15. Tejani A: Morphological transition in minimal change nephrotic
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